3.17

0.31% -0.01

Checkpoint Therapeutics Inc (CKPT)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Checkpoint Therapeutics Inc stock is traded at $3.17, with a volume of 218.57K. It is down -0.31% in the last 24 hours and up +5.67% over the past month. Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its lead small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor ("EGFR") inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.

Previous Close:

$3.18

Open:

$3.2

24h Volume:

218.57K

Relative Volume:

0.17

Market Cap:

$155.29M

Revenue:

$103.00K

Net Income/Loss:

$-42.47M

P/E Ratio:

-1.6684

EPS:

-1.9

Net Cash Flow:

$-34.30M

1W Performance:

-4.23%

1M Performance:

+5.67%

6M Performance:

+40.27%

1Y Performance:

+65.10%

1-Day Range:

$3.14

$3.23

1-Week Range:

$3.10

$3.425

52-Week Range:

$1.38

$4.50

Checkpoint Therapeutics Inc Stock (CKPT) Company Profile

Name

Checkpoint Therapeutics Inc

Sector

Healthcare (1174)

Industry

Biotechnology (677)

Phone

781-652-4500

Address

95 SAWYER ROAD, WALTHAM, NY

Employee

Twitter

Next Earnings Date

2024-11-11

Latest SEC Filings

CKPT's Discussions on Twitter

Compare CKPT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CKPT Checkpoint Therapeutics Inc	3.17	155.29M	103.00K	-42.47M	-34.30M	-1.90
VRTX Vertex Pharmaceuticals Inc	485.58	123.34B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	698.66	76.09B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	649.20	39.34B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	250.32	32.49B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	120.05	28.26B	3.30B	-501.07M	1.03B	-2.1146

Checkpoint Therapeutics Inc Stock (CKPT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-13-25	Initiated	D. Boral Capital	Buy
Jul-14-22	Resumed	B. Riley Securities	Buy
Jun-09-21	Initiated	B. Riley Securities	Buy
Jan-20-21	Initiated	Cantor Fitzgerald	Overweight
May-29-19	Initiated	Lake Street	Buy
Dec-08-17	Initiated	H.C. Wainwright	Buy

View All

Checkpoint Therapeutics Inc Stock (CKPT) Latest News

Feb 17, 2025

Checkpoint Therapeutics CEO sells $64,027 in stock - MSN

Feb 17, 2025

Feb 16, 2025

James F. Oliviero III Sells 9,233 Shares of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Stock - MarketBeat

Feb 16, 2025

Checkpoint Therapeutics CFO sells shares worth $271,983 - MSN

Feb 16, 2025

Feb 14, 2025

Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) CEO James F. Oliviero III Sells 10,331 Shares - MarketBeat

Feb 14, 2025

Feb 12, 2025

Checkpoint Therapeutics CEO sells $64,027 in stock By Investing.com - Investing.com South Africa

Feb 12, 2025

Feb 11, 2025

The Future of Immune Checkpoint Inhibitors Market: Industry Disruptions & Innovations to Expect - WICZ

Feb 11, 2025

Checkpoint Therapeutics CEO Sells Shares to Cover Tax Obligations - TradingView

Feb 11, 2025

Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) CFO Sells $271,983.70 in Stock - MarketBeat

Feb 11, 2025

Insider Sale Alert: Checkpoint Therapeutics Inc [CKPT] – Is it Time to sell? - Knox Daily

Feb 11, 2025

Feb 08, 2025

Checkpoint Therapeutics CFO sells shares worth $271,983 By Investing.com - Investing.com Canada

Feb 08, 2025

Feb 06, 2025

The time has not yet come to remove your chips from the table: Checkpoint Therapeutics Inc (CKPT) - SETE News

Feb 06, 2025

Analyzing Ratios: Checkpoint Therapeutics Inc (CKPT)’s Financial Story Unveiled - The Dwinnex

Feb 06, 2025

Feb 05, 2025

Technical analysis of Checkpoint Therapeutics Inc (CKPT) stock chart patterns - US Post News

Feb 05, 2025

Feb 04, 2025

Checking in on Checkpoint Therapeutics Inc (CKPT) after recent insiders movement - Knox Daily

Feb 04, 2025